GeneXpert CT/NG test for Chlamydia and Gonorrhoea diagnosis used at point of care: A single tertiary care centre experience
K. Khalid, N. Pudzi, V. Krishnasamy and 2 more
International Journal of Infectious Diseases · 2020
doi:10.1016/j.ijid.2020.09.1164 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Molecular testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is recommended worldwide and established evidence confirming that Nucleid Acid Amplification Test (NAAT)-based tests that can be used at point of care is significantly more sensitive than culture for detection of these sexually transmitted infections. We aimed to describe the demographic characteristics of patients who visited our centre with suspicion of CT/NG infections and to analyse the diagnostic performance of GeneXpert CT/NG test. Methods and materials: This was a retrospective, single-centre descriptive study carried out between January to October 2019 amongst patients with suspicion of CT/NG infections attending Genitourinary Medicine (GUM) clinic in a tertiary hospital. Demographic and clinical data were gathered using a face-to-face interview and a standardised patient clerking form. Urine and vulvo-vaginal samples were collected for microbiological and molecular analyses. Results: This study included 84 patients of which 67.9% were men and 32.1% were women. The mean age of patients was 30.8 years. 60.7% were Malays, followed by 22.6% Chinese, 15.5% Indians and 1.2% other races. Majority of them were men who have sex with men (MSM). There was a significant correlation between GeneXpert NG detection and presence of gram-negative cocci on swab microscopy (r = 0.453, n = 84, p < 0.001). Similarly, there was a significant correlation between GeneXpert NG detection and positive NG culture on conventional agar plate (r = 0.661, n = 84, p < 0.001). However, no significant correlation was seen between GeneXpert CT detection and absence of gram-negative cocci on swab microscopy (r = 0.205, n = 84, p = 0.062). Conclusion: GeneXpert CT/NG assay performance was highly accurate with rapid turnaround time and easy to use. This will potentially result in significant changes in patient management by enabling immediate treatment of CT/NG infections, more infection detection in asymptomatic individuals and prompt contact tracing. However, more cost-effectiveness studies are needed, especially in the low and middle income countries.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.